Approved CAR-T therapies have reproducible efficacy and safety in clinical practice

• প্রধান লেখক: Daniel Goyco Vera (লেখক), Hiral Waghela (লেখক), Mohamed Nuh (লেখক), Jonathan Pan (লেখক), Premal Lulla (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

CAR-T cell therapy has established itself as a highly effective treatment for hematological malignancies. There are currently six commercial CAR-T products that have been FDA approved for diseases such as B-ALL, LBCL, MCL, FL, MM, and CLL/SLL. "Real-world" studies allow us to evaluate outc...